Psoriasis and psoriatic arthritis in a patient with HIV: response to mycophenolate mofetil treatment.
A case of psoriasis and psoriatic arthritis in a 38-year-old white male patient infected with human immunodeficiency virus (HIV) treated safely and effectively with mycophenolate mofetil (MMF) is reported. Treatments for psoriasis and psoriatic arthritis are manifold, including topical, oral, intramuscular, intravenous, and subcutaneous therapies. These indicated treatments for psoriasis and psoriatic arthritis result in suppression of the immune system.
Forman
Seth B
SB
The University of Central Florida College of Medicine, Tampa, FL, USA. sethbforman@gmail
Higginson
Robert
R
Garrett
Algin B
AB
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D015535:Arthritis, Psoriatic / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D002990:Clobetasol / Q000627:therapeutic use; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011565:Psoriasis / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000473:pathology
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002990:Clobetasol; D009173:Mycophenolic Acid